"The GENERICS are pinning their whole case on this particular area and its up to AMARIN'S legal team to refute "WRITTEN DESCRIPTION" in their patents.."
How can they pin their whole case on "WRITTEN DESCRPTION" when their expert witnesses were not able to discuss WRITTEN DESCRIPTION".
From the way I am reading it the GENERICS are trying to convince the judge to be able to use "WRITTEN DESCRIPTION" in their arguments because they failed to have any of their expert witnesses address "WRITTEN DESCRIPTION" during their pre-trial expert witness testimony.
Con, do you think if Amarin could identify certain MARINE patents, which were written after the MARINE results came out in November of 2010, that were based on changes in some non-obvious lipid biomarkers, e.g. hs-CRP, should be enough to counter GENERICS' arguments? TIA.
News 
Market Data 
Discover 
